HONG KONG,March 18,2025-- In 2024,Roborock,the global leader in ultra-intelligent home robotics engineered to simplify daily life,ranked once again first in global sales volume and turnover amongst R
Deal reflects Liberty Mutual\'s conviction to its focused Asia Pacific strategy BOSTON,March 3,2025-- Liberty Mutual Insurance has agreed to sell its operations in Thailand and Vietnam to Chubb Limit
SHANGHAI,March 17,2025-- Singapore Treasure Carbon TechPte. Ltd. (SGTC) and CHCC Capital (Singapore) Pte. Ltd. have jointly launched a fund that will invest in international carbon credit assets compl
HANGZHOU,China,March 17,2025--Chance Pharmaceuticals ("Chance Pharma"),a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies,to
Six new models announced for AI-enhanced gaming,streaming,and creation with 8K visuals and optimized thermal design with triple FrostBlade 4.0 cooling fans
SINGAPORE,March 10,2025-- Singapore\'s largest real estate agency,PropNex Limited,has unveiled a refreshed brand logo after 25 years,signaling a new phase of growth and strategic direction. This mark
SUBANG JAYA,Malaysia,March 10,2025--Sunway Medical Centre,Sunway City (SMC) has yet again ranked in the top 250 hospitals globally in the latest Newsweek\'s World\'s Best Hospitals 2025 rankings.
NEW YORK,March 10,2025-- SunCar Technology Group Inc. ("SunCar" or the "Company") (NASDAQ: SDA),an innovative leader in auto e-insurance and cloud-based B2B auto services in China,
Service model accelerates service setup and time to revenue to support business growth HERNDON,Va.,March 11,2025-- ST Engineering iDirect,a global leader in satellite communications,today unveiled In
1Gb OctaFlash™ Memory Helps Enable Advanced AI Applications,3D-like GUI Experience HSINCHU,March 11,2025--Macronix International Co.,Ltd. (TSE: 2337),a leading integrated device manufacturer in the n
BEIJING and BRIDGEWATER,N.J.,March 10,2025-- Gan & Lee Pharmaceuticals(Gan & Lee,Shanghai Stock Exchange: 603087) announced that the first participant has been successfully dosed in a Phase 2